The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Common markers of proliferation
Abstract
When normal tissue and tumour samples are compared by microarray analysis, the biggest differences most often occur in the expression levels of genes that control cell proliferation. However, this difference is detected whenever mRNA samples that are taken from two cell populations with different proliferation rates are compared. Although the exact genes that comprise this 'proliferation signature' often differ, they are almost always genes that are involved in the fundamental process of cell proliferation. Can the proliferation signature be used to improve our understanding of the cell cycle and cancer pathogenesis, as well as being used as a biomarker for cancer diagnosis and prognosis?
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Haematoxylin and eosin (H&E) and KI67, a marker of cell proliferation22, staining of brainstem tumors from mice euthanized at the completion of 10 days treatment confirmed a dramatic reduction of tumor burden compared to controls (Fig. 4C).”
From Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas (2017) · cites this paper as [22]
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Molecular portraits of human breast tumours
Perou, C., Sørlie, T., Eisen, M., van de Rijn, M., Jeffrey, S., Rees, C. A., Pollack, J., Ross, D., Johnsen, H., Akslen, L., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,551
Self-citationSørlie, T., Perou, C. M., Tibshirani, R. J., Aas, T., Geisler, S. B., Johnsen, H., Hastie, T. J., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 11,506
Self-citationMootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Lossos, I. S., Rosenwald, A., Boldrick, J. C., Sabet, H., Tran, T., Yu, X., et al. (2000) · Nature · doi:10.1038/35000501 · Cited by 9,925
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
Paik, S., Shak, S., Tang, G., Kim, C., Baker, J. B., Cronin, M. T., Baehner, F. L., Walker, M. G., Watson, D., Park, T., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041588 · Cited by 6,321
Repeated observation of breast tumor subtypes in independent gene expression data sets
Sørlie, T., Tibshirani, R. J., Parker, J. S., Hastie, T. J., Marron, J. S., Nobel, A. B., Deng, S., Johnsen, H., Pesich, R., Geisler, S. B., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0932692100 · Cited by 5,508
Self-citationSpellman, P. T., Sherlock, G. J., Zhang, M. Q., Iyer, V. R., Anders, K. R., Eisen, M. B., Brown, P. O., Botstein, D., & Futcher, B. (1998) · Molecular Biology of the Cell · doi:10.1091/mbc.9.12.3273 · Cited by 4,724
Rosenwald, A., Wright, G. W., Chan, W. C., Connors, J. M., Campo, E., Fisher, R. I., Gascoyne, R. D., Müller-Hermelink, H. K., Smeland, E. B., Giltnane, J. M., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012914 · Cited by 3,832
Research works printed but not linked: 2
- Stewart, C. F. & Ratain, M. J. in Cancer: Principles and Practice in Oncology (eds. DeVita, V. T., Hellman, S. & Rosenberg, S. A.) 452–467 (Lippincott–Raven, Philadelphia, 1997).
- O'Dwyer, P. J., Johnson, S. W. & Hamilton, T. C. in Cancer Principles and Practices of Oncology (eds. DeVita, V. T., Hellman, S. & Rosenberg, S. A.) 418–432 (Lippincott–Raven, Philadelphia, 1997).
Cited by
Sorted by citations
Items 601–653 of 653
Transcriptomic analysis of Cr(VI)-induced changes in C2C12 cells during myogenic differentiation
Park, S. Y., & Sun, H. (2025) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2025.127714
Du, F., Cai, D., Liu, L., Gou, S., Li, Y., Bai, Y., Lei, H., Lan, J., Zheng, X., Shen, J., et al. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5418355
Celik, F. S., Altveş, S., & Güneş, C. E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26188942
“Growth-associated disorders, including cancer, can result from a malfunctioning cell cycle regulation system, and many tumors have elevated expression of cell cycle genes and the proteins they encode, which act as proliferation markers [14,15].”
Liu, S., Pang, X., Wang, L., Zhan, N., Wu, S., Deng, J., Jin, K., Bai, Y., Jiang, D., Qi, L., et al. (2025) · Mediators of Inflammation · doi:10.1155/mi/3930562
Prioritization of cell cycle regulated genes
Zakeri, G. (2013) · NORA - Norwegian Open Research Archives
Castelli, L. M., Cutillo, L., Souza, C. D. S., Sánchez-Martínez, Á., Granata, I., Lin, Y.-H., Myszczynska, M. A., Heath, P. R., Livesey, M. R., Ning, K., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15145929
Ono, H., Arai, Y., Furukawa, E., Narushima, D., Matsuura, T., Nakamura, H., Shiokawa, D., Nagai, M., Imai, T., Mimori, K., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16655589
Castelli, L. M., Cutillo, L., Souza, C. D. S., Sánchez-Martínez, Á., Granata, I., Lin, Y.-H., Myszczynska, M. A., Heath, P. R., Livesey, M. R., Ning, K., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15145995
Castelli, L. M., Cutillo, L., Souza, C. D. S., Sánchez-Martínez, Á., Granata, I., Lin, Y.-H., Myszczynska, M. A., Heath, P. R., Livesey, M. R., Ning, K., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15145956
Wang, H., Cui, H., Yang, X., & Peng, L. (2024) · Figshare · doi:10.6084/m9.figshare.26576084
Wang, H., Cui, H., Yang, X., & Peng, L. (2024) · Figshare · doi:10.6084/m9.figshare.26576081
Castelli, L. M., Cutillo, L., Souza, C. D. S., Sánchez-Martínez, Á., Granata, I., Lin, Y.-H., Myszczynska, M. A., Heath, P. R., Livesey, M. R., Ning, K., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15145959
Castelli, L. M., Cutillo, L., Souza, C. D. S., Sánchez-Martínez, Á., Granata, I., Lin, Y.-H., Myszczynska, M. A., Heath, P. R., Livesey, M. R., Ning, K., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15145968
Rao, Y., Zhu, C., Suen, H. C., Huang, S., Liao, J., Ker, D. F. E., Tuan, R. S., & Wang, D. M. (2022) · Figshare · doi:10.6084/m9.figshare.20408146
Hepkema, J., Lee, N. K., Stewart, B. J., Ruangroengkulrith, S., Charoensawan, V., Clatworthy, M. R., & Hemberg, M. (2023) · Figshare · doi:10.6084/m9.figshare.23962000
Castelli, L. M., Cutillo, L., Souza, C. D. S., Sánchez-Martínez, Á., Granata, I., Lin, Y.-H., Myszczynska, M. A., Heath, P. R., Livesey, M. R., Ning, K., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15145935
Wang, H., Cui, H., Yang, X., & Peng, L. (2024) · Figshare · doi:10.6084/m9.figshare.26576075
Castelli, L. M., Cutillo, L., Souza, C. D. S., Sánchez-Martínez, Á., Granata, I., Lin, Y.-H., Myszczynska, M. A., Heath, P. R., Livesey, M. R., Ning, K., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15145947
Castelli, L. M., Cutillo, L., Souza, C. D. S., Sánchez-Martínez, Á., Granata, I., Lin, Y.-H., Myszczynska, M. A., Heath, P. R., Livesey, M. R., Ning, K., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15145965
Castelli, L. M., Cutillo, L., Souza, C. D. S., Sánchez-Martínez, Á., Granata, I., Lin, Y.-H., Myszczynska, M. A., Heath, P. R., Livesey, M. R., Ning, K., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15145962
Hepkema, J., Lee, N. K., Stewart, B. J., Ruangroengkulrith, S., Charoensawan, V., Clatworthy, M. R., & Hemberg, M. (2023) · Figshare · doi:10.6084/m9.figshare.23962003
Hepkema, J., Lee, N. K., Stewart, B. J., Ruangroengkulrith, S., Charoensawan, V., Clatworthy, M. R., & Hemberg, M. (2023) · Figshare · doi:10.6084/m9.figshare.23961997
Castelli, L. M., Cutillo, L., Souza, C. D. S., Sánchez-Martínez, Á., Granata, I., Lin, Y.-H., Myszczynska, M. A., Heath, P. R., Livesey, M. R., Ning, K., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15145971
Castelli, L. M., Cutillo, L., Souza, C. D. S., Sánchez-Martínez, Á., Granata, I., Lin, Y.-H., Myszczynska, M. A., Heath, P. R., Livesey, M. R., Ning, K., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15145944
Castelli, L. M., Cutillo, L., Souza, C. D. S., Sánchez-Martínez, Á., Granata, I., Lin, Y.-H., Myszczynska, M. A., Heath, P. R., Livesey, M. R., Ning, K., et al. (2021) · Figshare · doi:10.6084/m9.figshare.15145974
Wang, H., Cui, H., Yang, X., & Peng, L. (2024) · Figshare · doi:10.6084/m9.figshare.26576078
Proliferation-cycle gene signatures predict immune landscape and prognosis in lung adenocarcinoma
Lin, C., Zhang, M., Sun, P., He, Y., Tian, Y., Li, W., Pu, S., Luo, J., & Wang, K. (2025) · Discover Oncology · doi:10.1007/s12672-025-04346-6
“Emerging evidence highlights the critical roles of cell proliferation and cell cycle-related genes in driving tumorigenesis, progression, metastasis, and modulating anti-tumor responses [45, 46].”
Kalsnes, J., Isaksen, M. X., Julbø, F. M. I., Pradhan, M., Kleppe, A., de Raedt, S., Skrede, O.-J., Torheim, T., Nesheim, J. A., Mohn, H. M., et al. (2026) · FEBS Open Bio · doi:10.1002/2211-5463.70210
“Common markers of cellular proliferation include Ki67, proliferating cell nuclear antigen (PCNA), phosphohistone H3 (PHH3) and mitotic figure counting [2].”
Kurlekar, S., Lima, J. D. C. C., Kupfer, N., Pugh, C. W., Mole, D. R., Adam, J., & Ratcliffe, P. J. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.18.706657
“Endogenous avidin and biotin activity was blocked with the Avidin and Biotin Blocking kit (Abcam ab64212) for 5 min each at RT. Non-specific protein binding was blocked with 5% (w/v) BSA 10% (v/v) donkey serum in TBS-T for 1 hr at RT. Sections were incubated overnight at 4°C with the following primary antibodies, all…”
InfluentialRibonuclease 5/Angiogenin Suppresses Intestinal Tumor Initiation by Maintaining Crypt Homeostasis
Shi, X., Chen, J., Bai, R., Bai, H., Liu, Y., Yao, Z., Chu, W., Xu, X., Shen, N., Mao, Y., et al. (2026) · Cancer Research · doi:10.1158/0008-5472.can-25-1827
Park, Y. E., Kim, D. Y., Park, J. S., Lee, S., Park, Y., Kang, T., & Park, M. K. (2026) · Pharmaceuticals · doi:10.3390/ph19091451
“To validate the proliferation-inducing effect of RC extracts in fibroblasts, Ki-67, a prominent proliferation marker [24,25], was also detected by immunofluorescence staining (Figure 3B).”
Mise au point et développement de modèles hépatiques complexes par bio-impression 3D
Cuvellier, M. (2020) · theses.fr (ABES) · doi:10.70675/b6c577cdzcaffz460az8214z9681de8f3941
Clinical Translatable and Transparency of Neural Network for Blood-Based Personalized Cancer Risk
Malara, N., Gentile, F., Mancuso, T., Ferrazzo, T., Garo, N. C., Pacetti, S., Puccio, F., Candeloro, P., & Coluccio, M. L. (2026) · Mayo Clinic Proceedings Digital Health · doi:10.1016/j.mcpdig.2026.100359
“21 The proliferation rate influences the expression of multiple genes simultaneously as many genes act together, 22 either being positively correlated or anticorrelated.”
Lee, Y., & Lee, S.-Y. (2026) · Journal of Analytical Science & Technology · doi:10.1186/s40543-026-00537-0
Singh, A., & Lakkaniga, N. R. (2026) · Molecular Carcinogenesis · doi:10.1002/mc.70132
(1682), J. Z., Li, M., Li, Q., Fu, B., Li, Y., & Mi, S. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04633-6
“Malignant proliferation is a feature of most tumor cells and is correlated with tumor progression, treatment resistance, and poor clinical outcomes [1, 2].”
Galectin and Myc enable cochlear progenitor expansion in vitro and in vivoPreprint
Kubota, M., Abitbol, J. M., Lee, P. K., Matern, M. S., Barocio, S. B., Jan, T. A., Cheng, A. G.-L., & Heller, S. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.03.729765
Lyu, J., Kuramoto, Y., Li, J., Lee, J.-K., Hidaka, K., & Sakata, Y. (2026) · Chemical Biology & Drug Design · doi:10.1111/cbdd.70337
“…scoring algorithm robust to library-size variation and dropout events characteristic of sparse single-nucleus data, with eight canonical proliferation markers (Mohamed et al. 2018; Nguyen et al. 2024; Whitfield et al. 2006): AURKB , BUB1 , CCNB1 , CDCA8 , CDK1 , MKI67 , PLK1 , and TOP2A .”
Tuning BMP-Regulated Cell Differentiation in the Aortic Media by Mutating Matrix Gla Protein
Cai, X., Gunasinghe, K. K. J., Qi, L., Zhang, L., Wu, X., Jing, Z., Zhao, Y., Kim, H., Yao, E., Hsiai, T. K., et al. (2026) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.126.324621
A systems-level proteomic analysis identifies kinesin targets of KIFBP during neuronal developmentPreprint
Paschall, S., Blasius, T. L., Missman, A., Rodriguez, P., Cianfrocco, M. A., Verhey, K. J., & Stumpff, J. K. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.17.739260
“(Alberts et al., 2003; Couillard-Despres et al., 2005; Massacci et al., 2023; Whitfield et al., 2006) (Figure 1D).”
Cancer-associated mesothelial cells drive immune escape and therapy resistance in ovarian cancer
Chauvin, M. Y., Roche-Prellezo, J., Lafont, V., Michaud, H., Tromelin, E., Michel, R., Freixinos, C., Meinsohn, M.-C., Colombo, P., Bonnefoy, N., et al. (2026) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2026-015236
“Clustering of MCs ( Upk3b +/ Lrrn4 +) revealed a distinct subset enriched in CXCL/CCL chemokines (Cytokine-MCs:”
Le, J. T., Kim, E. K., Srivastava, V., Nakagawa, R. M., Phong, K. T., Childree, G., Moser, B., Goga, A., & Gartner, Z. J. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.01.742267
“Two further programs, 6 and 7, captured shared proliferative activity and corresponded to the S ( Pcna, Mcm5, Mcm6 ) and G2/M ( Birc5, Cenpf, Tpx2 ) phases of the cell cycle, respectively 19,20 .”
Galectin and Myc enable cochlear progenitor expansion in vitro and in vivoPreprint
Kubota, M., Abitbol, J. M., Lee, P. K., Matern, M. S., Barocio, S. B., Jan, T. A., Cheng, A. G.-L., & Heller, S. (2026) · eLife · doi:10.7554/elife.111365.1
Galectin and Myc enable cochlear progenitor expansion in vitro and in vivoPreprint
Kubota, M., Abitbol, J. M., Lee, P. K., Matern, M. S., Barocio, S. B., Jan, T. A., Cheng, A. G.-L., & Heller, S. (2026) · eLife · doi:10.7554/elife.111365
Song, X., Nica, C., Stähli, A., Sculean, A., & Asparuhova, M. B. (2026) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.70202
Takahashi, H., Uchida, M., Takahashi, K., Hagiwara, H., Tada, H., Matsuyama, T., & Chikamatsu, K. (2026) · Cancers · doi:10.3390/cancers18193104
Elp1 is required for myeloid differentiation and brain repopulation
Mader, M. M.-D., Li, W., Scavetti, A., Yoo, Y., Neumayer, G., Han, K., Shibuya, Y., Haney, M. S., Wyss‐Coray, T., George, L., et al. (2026) · Nature · doi:10.1038/s41586-026-11112-3
Self-citationCruz, C., Miranda, A., Benigno, D., Lourenço, P., Moreira, D., Pecoraro, A., Russo, A., Russo, G., Virgilio, A., Esposito, V., et al. (2026) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2026.110665
BindingDB Entry 50044150: Thes2 receptor: a novel protein for the imaging and treatment of cancer.
BindingDB (2015) · UC San Diego · doi:10.7270/q22r3t54
Diagnostic and Prognostic Cancer Biomarkers: From Traditional to Systems Approaches
Buffa, F. M., & Harris, A. L. (2011) · Springer eBooks · doi:10.1007/978-94-007-1567-7_13
Metadata
- Authors
- Whitfield, M. L., George, L. K., Grant, G. D., & Perou, C. M.
- Affiliations
- Dartmouth College (US)
- University of North Carolina at Chapel Hill (US)
- Corresponding author
- Whitfield, Michael L.
- Venue
- Nature Reviews Cancer
- Published
- 2006-02
- Volume
- 6
- Issue
- 2
- Pages
- 99-106
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2018173663
- Cited by
- 650
- References
- 66
- Citations by year
- 2026: 31 · 2025: 46 · 2024: 35 · 2023: 54 · 2022: 53 · 2021: 54 · 2020: 33 · 2019: 29 · 2018: 22 · 2017: 27 · 2016: 34 · 2015: 15 · 2014: 17 · 2013: 27 · 2012: 26
- FWCI
- 2.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- cell proliferation, proliferation signature, gene expression profiling, tumor markers, cell cycle, carcinogenesis, cancer diagnosis, cancer prognosis
- MeSH terms
- Cell Cycle, Genetic Markers, Humans, Neoplasms, Prognosis, RNA, Messenger, Biomarkers, Tumor, Gene Expression Profiling, Cell Proliferation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review